EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Short Interest Update
EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Short Interest Update
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 21,500 shares, an increase of 6.4% from the December 31st total of 20,200 shares. Based on an average trading volume of 14,700 shares, the short-interest ratio is presently 1.5 days.
Effector Therapeutics, Inc.（纳斯达克股票代码：EFTRW — Get Rating）在1月份的空头利率大幅增加。截至1月15日，空头利率共计21,500股，较12月31日的20,200股增长了6.4％。根据14,700股的平均交易量，目前的空头利率为1.5天。
eFFECTOR Therapeutics Trading Down 11.6 %
Effector Therapeutics 交易下跌
Shares of NASDAQ EFTRW opened at $0.14 on Wednesday. The firm's fifty day moving average is $0.14 and its two-hundred day moving average is $0.15. eFFECTOR Therapeutics has a 52-week low of $0.04 and a 52-week high of $0.73.
纳斯达克EFTRW的股价周三开盘价为0.14美元。该公司的五十天移动平均线为0.14美元，其两百天移动平均线为0.15美元。Effector Therapeutics的52周低点为0.04美元，52周高点为0.73美元。
See Also
另见
- Get a free copy of the StockNews.com research report on eFFECTOR Therapeutics (EFTRW)
- Verizon, Charter Trend Higher In Past Month: Are They Buys Now?
- Dividend King Sysco: Buying On The Dip
- Is the 1,600% Rise in Genius Group Stock Justified?
- After Further Review, Investors Liked Exxon Mobil's Earnings
- Will Caterpillar Dig Its Way To Another Buying Opportunity?
- 免费获取 StockNews.com 关于 Effector Therapeutics（EFTRW）的研究报告
- Verizon、Charter在过去一个月中呈上升趋势：他们现在买了吗？
- 股息之王 Sysco：逢低买入
- Genius集团股票上涨1,600％是否合理？
- 经过进一步审查，投资者喜欢埃克森美孚的收益
- 卡特彼勒会挖掘另一个买入机会吗？
Receive News & Ratings for eFFECTOR Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eFFECTOR Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收 Effector Therapeutics 的新闻 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Effector Therapeutics及相关公司的最新新闻和分析师评级的简明每日摘要。
